ROLE OF LHRH ANALOGUE IN CASES OF REFRACTORY MASTALGIA.
article
OA: closed
CC0
Abstract
Background: Mastalgia is the commonest cause of visit to the breast clinic. The present study was conducted to assess the efcacy of complete estrogen blockade (CEB) with centchroman and LHRH analog goserelin in the treatment of refractory mastalgia. Aim: To study the effect of LHRH analogue in refractory mastalgia and to increase pain free period in patients with refractory mastalgia. Methods: This is a prospective cohort study conducted in the Dept.Of Gen.Surgery IGIMS ,Patna over a period of six months.The reduction of pain score ( as measured by a visual analog scale (VAS) recorded on a breast pain chart ) to 3 or less at 6 weeks of initiation of treatment was taken as primary objective. Results: Fifty patients were enrolled in the study. The mean age of the patients was 28 years (15–45 years). The median duration of symptoms was 6 months (4–8). All of them had bilateral mastalgia. The mean pain score at start of study was 7. Conclusion: Complete estrogen blockade by means of GNRH analogue is safe and effective for treatment of refractory mastalgia.
My notes (saved in your browser only)
Outcome instruments
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (5)
- CLINICAL EXPERIENCE OF DRUG TREATMENTS FOR MASTALGIA via openalex
- doi:10.1016/j.ajog.2004.06.100 via openalex
- doi:10.1007/s12262-016-1492-z via openalex
- doi:10.1007/s00268-007-9040-4 via openalex
- doi:10.1016/j.ijsu.2014.12.033 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:25:57.662601+00:00
License: CC0
· commercial use OK